Medifast Q3 2024 revenue down 40.6% to $140.2M; EPS $0.10; guides Q4 revenue $100-120M

MEDIFAST INC

2024-Q3 EPS reported $0.12 revenue$483,460,000

Revenue $140.2M, down 40.6% YoY; net income $1.1M ($0.10 diluted EPS); adjusted EPS $0.35.
Active earning OPTAVIA coaches fell 36.3% to 30,000; average revenue per coach $4,672 (down from $5,008).
Cash $170M, no debt; credit facility canceled, saving ~$500k annual commitment fees.
Q4 2024 guidance: revenue $100-120M, diluted loss per share $0.10-$0.65.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.